C
Core Research Group Pty Ltd | Brisbane, Australia
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
Povetacicept
INS068
Tirzepatide
ABP-745
LY3298176
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
3 of 6 total trials
This study is designed to evaluate the efficacy and safety of intravenously administered YN001 in patients diagnosed with coronary atherosclerosis, w...
Enrolling
Coronary Artery Disease
Atherosclerosis
Drug: YN001/Placebo 40mg
Drug: YN001/Placebo 20mg
This is a multicenter, randomized, double-blind, placebo parallel controlled study to evaluate the preliminary efficacy, safety, and PopPK profile of...
Enrolling
ASCVD Management
Atherosclerosis Cardiovascular Disease
Drug: ABP-745 Dose C
Drug: ABP-745 Dose A
The purpose of this study is to evaluate the efficacy of povetacicept in adult participants compared with placebo in reducing proteinuria and preserv...
Active, not recruiting
Immunoglobulin A Nephropathy
Drug: Placebo (matched to Povetacicept)
Drug: Povetacicept
Trial sponsors
B
R
A
A
Clinical trials
Research sites
Resources
Legal
© Copyright 2026 Veeva Systems